Literature DB >> 29557215

The evolution of practical radiobiological modelling.

B Jones1, R G Dale2.   

Abstract

A summary of the key aspects of radiobiological modelling is provided, based on the theoretical and practical concepts of the linear quadratic model, which gradually replaced other numerical approaches. The closely related biological effective dose concept is useful in many clinical applications. Biological effective dose formulations in conventional photon-based radiotherapy continue to be developed, and can be extended to the now increasingly used proton and ion-beam therapy, to very low or high dose ranges, the dose rate effect, hypoxia and repopulation. Such established and new research developments will be of interest to clinicians, physicists and biologists to better understand the processes underlying radiotherapy and assist their collaborative efforts to make radiotherapy safer and more effective.

Entities:  

Mesh:

Year:  2018        PMID: 29557215      PMCID: PMC6435084          DOI: 10.1259/bjr.20180097

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  51 in total

1.  Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-, (12)C- and (20)Ne-ion beams.

Authors:  Y Furusawa; K Fukutsu; M Aoki; H Itsukaichi; K Eguchi-Kasai; H Ohara; F Yatagai; T Kanai; K Ando
Journal:  Radiat Res       Date:  2000-11       Impact factor: 2.841

2.  Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.

Authors:  Jack F Fowler; Paul M Harari; Felix Leborgne; José H Leborgne
Journal:  Radiother Oncol       Date:  2003-11       Impact factor: 6.280

Review 3.  Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells.

Authors:  B Marples; B G Wouters; S J Collis; A J Chalmers; M C Joiner
Journal:  Radiat Res       Date:  2004-03       Impact factor: 2.841

4.  Adaptation of the microdosimetric kinetic model to hypoxia.

Authors:  C Bopp; R Hirayama; T Inaniwa; A Kitagawa; N Matsufuji; K Noda
Journal:  Phys Med Biol       Date:  2016-10-07       Impact factor: 3.609

5.  Radiation-induced cell death by chromatin loss. A model to explain the shape of low-linear-energy-transfer cell survival curves.

Authors:  I R Campbell; H M Warenius
Journal:  Br J Radiol       Date:  1989-04       Impact factor: 3.039

Review 6.  Pre-operative and post-operative irradiation.

Authors:  O Scott
Journal:  Br Med Bull       Date:  1973-01       Impact factor: 4.291

7.  An 'incomplete-repair' model for survival after fractionated and continuous irradiations.

Authors:  H D Thames
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1985-03

8.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

Authors:  R G Dale
Journal:  Br J Radiol       Date:  1985-06       Impact factor: 3.039

Review 9.  Low-dose hypersensitivity: current status and possible mechanisms.

Authors:  M C Joiner; B Marples; P Lambin; S C Short; I Turesson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-02-01       Impact factor: 7.038

10.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Authors:  Joanne S Haviland; J Roger Owen; John A Dewar; Rajiv K Agrawal; Jane Barrett; Peter J Barrett-Lee; H Jane Dobbs; Penelope Hopwood; Pat A Lawton; Brian J Magee; Judith Mills; Sandra Simmons; Mark A Sydenham; Karen Venables; Judith M Bliss; John R Yarnold
Journal:  Lancet Oncol       Date:  2013-09-19       Impact factor: 41.316

View more
  6 in total

1.  A Multi-Compartment Model of Glioma Response to Fractionated Radiation Therapy Parameterized via Time-Resolved Microscopy Data.

Authors:  Junyan Liu; David A Hormuth; Jianchen Yang; Thomas E Yankeelov
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

2.  Radiotherapy treatment interruptions during the Covid-19 pandemic: The UK experience and implications for radiobiology training.

Authors:  R G Dale; B Jones
Journal:  Radiat Phys Chem Oxf Engl 1993       Date:  2022-05-06       Impact factor: 2.776

3.  Use of radiobiology in medical jurisprudence, with particular reference to delays in diagnosis and therapeutic onset.

Authors:  Bleddyn Jones
Journal:  Br J Radiol       Date:  2019-11-07       Impact factor: 3.039

4.  Modelling the influence of treatment time on the biological effectiveness of single radiosurgery treatments: derivation of "protective" dose modification factors.

Authors:  Bleddyn Jones; John W Hopewell
Journal:  Br J Radiol       Date:  2018-08-21       Impact factor: 3.039

5.  Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy.

Authors:  Xian-Shu Gao; Yuta Shibamoto; Ming Cui; Xiaoying Li; Mingwei Ma; Xin Qi
Journal:  Radiat Oncol       Date:  2022-03-18       Impact factor: 3.481

6.  The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.

Authors:  Christopher S Graffeo; Diane Donegan; Dana Erickson; Paul D Brown; Avital Perry; Michael J Link; William F Young; Bruce E Pollock
Journal:  Neurosurgery       Date:  2020-09-01       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.